| 영문 | icterus, jaundice | 한글 | 황달 |
|---|---|---|---|
| 설명 | 혈액 중에 빌리루빈 양이 증가하여 피부 및 점막내 담즙의 축적으로 황색을 나타내는 병적상태. 빌리루빈은 적혈구에 함유되는 혈색소의 체내에서의 대사산물이며, 간 또는 그 밖의 특수한 세포 속에서 만들어지고 쓸개즙 속에 함유되어 배설되는 적황색 색소이다. 원인은 다음과 같이 셋으로 크게 나눈다. ① 폐색성 황달: 쓸개돌이나 종양 등에 의하여 담관에서 장관으로 유출되어야 할 담즙이 쓸개관의 폐색에 의하여 유출장애를 일으킨 경우. ② 간세포성 황달 및 간세쓸개관성 황달: 간세포의 기능장애에 의한 담즙분비장애를 일으키는 경우로 급성간염에 의하여 대표되는 것. ③ 용혈황달: 과잉의 혈구 파괴로 인하여 일어나는 것으로 주로 용혈성 빈혈인 경우에 일어나는 것이 있다. 또 증세를 경중에 따라 구별하면, 카타르성 황달은 경도의 증세인 경우이며, 두통-권태감 외에 맥박이 느려지고, 때로는 피부가 가려워진다. 중증 황달은 위독한 증세이며, 발열-간부분의 통증, 혼수 등을 볼 수 있고, 급성 간위축증-간경화증-간암 등의 경우에 볼 수 있다. |
||
| CBD | Common Bile Duct - Absolute Ix of CBD Exploration 1. Palp... |
|---|---|
| EOJ | extrahepatic obstructive jaundice |
| jaund | jaundice |
| OJ | Obstructive jaundice |
|---|---|
| AIHA | Auto-immune haemolytic anaemia |
| AHA | autoimmune haemolytic anaemia |
| GABHS | Group A beta haemolytic streptococcus |
| GABHS | Group A beta-haemolytic streptococci |
| haemolytic jaundice | <haematology> Haemolytic jaundice is a type of jaundice, where the skin takes on a yellowish hue, which occurs when red blood cells have been destroyed (by haemolysis). (09 Oct 1997) |
|---|
| congenital haemolytic jaundice | <haematology> A hereditary disorder that leads to a chronic haemolytic anaemia due to an abnormality in the red blood cell membrane. This disorder is caused by a defective gene. Red cells are resistant to stress and rupture easily. Infants may appear jaundiced and pale. Fatigue, weakness and shortness of breath are other symptoms that may be seen in older patients. The spleen may also be enlarged. Treatment includes splenectomy (removal of the spleen). After this is accomplished the life-span of the red blood cells returns to normal. (27 Sep 1997) |
|---|---|
| ABO haemolytic disease of the newborn | Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes. (05 Mar 2000) |
| acquired haemolytic anaemia | Nonhereditary acute or chronic anaemia associated with or caused by extracorpuscular factors, e.g., certain infectious agents, chemicals (including autoantibodies or therapeutic agents), burns, toxic materials from higher plant and animal forms (including snake venoms). (05 Mar 2000) |
| acquired haemolytic icterus | Icterus and anaemia occuring in association with a moderate degree of splenomegaly, increased fragility of red blood cells, and increased amounts of urobilin in the urine. Synonym: icteroanaemia. Origin: G. Ikteros (05 Mar 2000) |
| anaemia, haemolytic | Anaemia due to decreased life span of erythrocytes. (12 Dec 1998) |
| anaemia, haemolytic, autoimmune | Acquired haemolytic anaemia due to the presence of autoantibodies which agglutinate or lyse the patient's own red cells. (12 Dec 1998) |
| anaemia, haemolytic, congenital | Haemolytic anaemia due to various intrinsic defects of the erythrocyte. (12 Dec 1998) |
| anaemia, haemolytic, congenital nonspherocytic | Any one of a group of congenital haemolytic anaemias in which there is no abnormal haemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. In some cases, pyruvate kinase deficiency has been demonstrated; in other cases, glucose-6-phosphate dehydrogenase deficiency has been demonstrated. (12 Dec 1998) |
| angiopathic haemolytic anaemia | A rare postpartum anaemia of unknown aetiology with uraemia and nephrosclerosis; may be a rare complication following use of contraceptive steroids. (05 Mar 2000) |
| autoimmune haemolytic anaemia | <haematology> A condition that results from the cellular destruction (haemolysis) of red blood cells due to antibodies formed to components on the surface of the red blood cells. Origin: Gr. Haima = blood (02 Jan 1998) |
| beta-haemolytic streptococci | Those that produce active haemolysins (O and S) which cause a zone of clear haemolysis on the blood agar medium in the area of the colony; beta-haemolytic streptococci are divided into groups (A to O) on the basis of cell wall C carbohydrate (see Lancefield classification); Group A (in the strains pathogenic for man) comprises more than 50 types (designated by Arabic numerals) determined by cell wall M protein, which seems to be associated closely with virulence and is produced chiefly by strains with matt or mucoid colonies, in contrast to nonvirulent, glossy colony-producing strains; other surface protein antigens such as R and T (T substance), and the nucleoprotein fraction (P substance) seem to be of less importance. The more than 20 extracellular substances elaborated by strains of beta-haemolytic streptococci include erythrogenic toxin (elaborated only by lysogenic strains), deoxyribonuclease (streptodornase), haemolysins (streptolysins O and S), hyaluronidase, and streptokinase. Synonym: haemolytic streptococci. (05 Mar 2000) |
| microangiopathic haemolytic anaemia | <haematology> Consequence of disseminated intravascular coagulation (DIC): fragments of red blood cells, damaged by being forced through a fibrin meshwork, are found in the circulation. Origin: Gr. Haima = blood (18 Nov 1997) |
| complement haemolytic activity assay | Usual screening assay for complement. Dilutions of the serum to be tested are added to antibody-coated erythrocytes and the percentage of lysis is measured. The values are expressed by ch50, haemolytic complement units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay. (12 Dec 1998) |
| congenital haemolytic anaemia | Accelerated destruction of red blood cells due to an inherited defect, such as in the membrane in hereditary spherocytosis. (05 Mar 2000) |
| congenital haemolytic icterus | <haematology> A hereditary disorder that leads to a chronic haemolytic anaemia due to an abnormality in the red blood cell membrane. This disorder is caused by a defective gene. Red cells are resistant to stress and rupture easily. Infants may appear jaundiced and pale. Fatigue, weakness and shortness of breath are other symptoms that may be seen in older patients. The spleen may also be enlarged. Treatment includes splenectomy (removal of the spleen). After this is accomplished the life-span of the red blood cells returns to normal. (27 Sep 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|